Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether exenatide can cause weight loss in patients
with a history of craniopharyngioma or other brain lesion.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center